2020
Jul
10
Stay Connected
Subscribe to our mailing list to receive CFAR-related news, events, and funding opportunities.
Harvard CFAR Twitter Feed
-
t.co/yDGvvQUudp - HIV Research Highlights from AIDS 2020 t.co/TBbA2z2ifG
-
“[Women] make up half of the people living with #HIV, and maintaining gender #equity in HIV treatment outcomes really requires pregnancy safety data.” -Dr. Rebecca Zash @theziti @BIDMChealth @harvardmed @AIDS_conference #Botswana t.co/OJOM02EZBs
-
Fantastic #PrEP news! And while the shot was found to be more effective than the pill, Truvada is 99% effective when taken daily, can be provided through telehealth, and will go generic later this year. If it's working for you, stick with it! t.co/TkAEjiaXD7
-
Long-acting injectable form of HIV prevention outperforms daily pill in NIH study t.co/4wF0ZgFZ07
Welcome
The mission of the HU CFAR is to expand, promote and facilitate collaborative innovative multidisciplinary activities in HIV/AIDS research in order to bring an end to the epidemic.
Upcoming Events
Recent News
Acknowledging the CFAR to Remain in Compliance
Please be sure to acknowledge CFAR support in order to remain in compliance with NIH policy. Acknowledgment and NIH Disclaimer was updated on 12/23/2013.